In February 1945, Franklin Delano Roosevelt, then U.S. president, arrived at the Yalta Conference to negotiate the post-war future of Europe alongside Winston Churchill and Joseph Stalin. The American president appeared visibly exhausted, lethargic and physically frail. Behind those images lay a silent medical crisis. Roosevelt’s blood pressure had reached around 260/150 mm Hg before the conference. Only weeks later, on April 12, 1945, Roosevelt collapsed at Warm Springs, Georgia, after complaining of a severe headache. His blood pressure reportedly exceeded 300/190 mm Hg before he died of a massive cerebral haemorrhage at the age of 63. Today, such readings would trigger immediate intensive care management. Yet Roosevelt’s physicians did not aggressively attempt to reduce his blood pressure.

Earlier medical thinking

The reason reflected the medical thinking of the era. Until the middle of the 20th century, many physicians did not consider hypertension to be a disease requiring active treatment. Elevated blood pressure was widely viewed as a natural accompaniment of ageing and a protective mechanism necessary to maintain blood flow to vital organs. In 1931, British cardiologist J.H. Hay famously remarked that “the greatest danger to a man with high blood pressure lies in its discovery because then some fool is certain to try and reduce it.” Physicians feared that lowering blood pressure could produce circulatory collapse, kidney injury or stroke.

Even in the first edition of Harrison’s Principles of Internal Medicine published in 1950, treatment recommendations remained cautious and largely symptom-driven. Therapy was generally reserved for patients who already showed overt cardiovascular complications. Part of this hesitation stemmed from the fact that medicine had few reliable treatments. Available approaches included sedatives, prolonged bed rest, severe salt restriction and radical surgeries such as sympathectomy. Many interventions carried serious adverse effects. But another reason was scientific uncertainty itself. Physicians still lacked convincing evidence that hypertension independently caused disease rather than merely accompanying vascular ageing.

The Framingham study

An intellectual transformation began after the Second World War, driven by the rise of epidemiology. In 1948, the Framingham Heart Study was launched in Massachusetts. It became one of the world’s largest and most influential cohort studies. Thousands of individuals were followed for decades to understand why some developed cardiovascular disease while others did not. The study fundamentally altered medicine. Researchers demonstrated that elevated blood pressure strongly predicted stroke, coronary artery disease, heart failure and kidney damage even among apparently healthy individuals. Hypertension emerged as a major independent cardiovascular risk factor. The Framingham study also transformed the philosophy of medicine itself. Physicians increasingly realised that chronic diseases evolved silently, driven by measurable risk factors, years before symptoms appeared. Blood pressure, cholesterol, smoking and diabetes became central to a new preventive framework in medicine. Modern preventive cardiology emerged from this transition.

The veterans trial

Despite Framingham’s observations, many physicians remained sceptical. Observational evidence alone did not fully convince the medical community. The decisive turning point came in 1967 through the landmark Veterans Administration Cooperative Study. This randomised clinical trial demonstrated that actively lowering blood pressure significantly reduced strokes, heart failure and kidney damage among patients with severe hypertension. Physicians possessed convincing experimental evidence through the study that treatment itself altered survival. The Veterans study changed the trajectory of cardiovascular medicine. Hypertension could no longer be dismissed as a harmless consequence of ageing. The debate gradually shifted from “Should hypertension be treated?” to “How early should treatment begin?”

Over subsequent years, repeated clinical trials, epidemiological studies, and the growing science of evidence synthesis consistently reinforced the same conclusion. Even though the precise cause of most hypertension remained unknown, the cumulative evidence clearly showed that elevated blood pressure silently damaged blood vessels, kidneys, the retina, the heart and the brain over time. Medicine increasingly accepted hypertension as a disease entity in its own right.

JNC era

The final consolidation of medical consensus arrived in 1977 with the publication of the first report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, commonly known as JNC. Hypertension was systematically classified, monitored, and managed in accordance with standardised national recommendations. The report helped unify physicians, researchers and public health systems around a common framework for detection and treatment. The JNC recommendations evolved over subsequent decades as more evidence accumulated. Treatment thresholds became progressively stricter. Greater emphasis was placed on systolic blood pressure, early detection and long-term prevention. What began as a controversial physiological observation gradually became one of the most important measurable diseases in preventive medicine.

What remains puzzling

Yet hypertension continues to retain an important scientific mystery. Even today, most patients (>90%) are classified as having “essential hypertension,” meaning no single identifiable cause can be pinpointed. Medicine recognises multiple risk factors, including genetics, obesity, excess salt intake, stress, alcohol, ageing, and sedentary lifestyles. But the precise biological mechanisms through which these factors interact remain incompletely understood. In many ways, hypertension became recognised as a disease not because medicine fully understood its cause, but because epidemiology, clinical trials and evidence synthesis repeatedly demonstrated its devastating long-term consequences. This represented a major maturation of modern medicine itself. Diseases no longer required a single visible cause to justify intervention. Statistical evidence, reproducible outcomes and longitudinal population studies became sufficient to guide public health action.

The progress so far

Roosevelt’s represents a textbook case of untreated hypertension progressing to target organ failure and death from stroke. In less than a century since his death, humanity moved from therapeutic helplessness and scientific uncertainty to highly effective blood pressure control using inexpensive medicines with relatively few side effects. Today, antihypertensive drugs are available even in small primary health centres, sub-centres and remote rural clinics across much of the world. And yet, a vast majority in India continue to remain untreated or under-treated, signalling the need for better public health interventions.

Had modern antihypertensive therapy and contemporary cardiovascular care been available to Franklin D. Roosevelt though, the political fate of Eastern Europe, negotiated in the shadow of his failing health, may have unfolded differently at the Yalta conference.

(Dr. C. Aravinda is an academic and public health physician. The views expressed are personal. aravindaaiimsjr10@hotmail.com)